Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, Other*
-
Stock Symbol
-
KYMR on Nasdaq
Bvf Partners L P/Il - trading volume in the past year for Kymera Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock, $0.0001 par value |
295K |
$13.7M |
$46.41 |
Aug 20, 2024 |
Direct |
|
|
Pre-Funded Warrants to Purchase Common Stock |
157K |
$6.39M |
$40.75 |
Aug 20, 2024 |
Direct |
Common Stock, $0.0001 par value |
52.7K |
Stock Option (Right to Buy) |
12K |
|
|
Aug 20, 2024 |
Indirect |
Common Stock, $0.0001 par value |
12K |
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.